Moxifloxacin Ophthalmic

282 interactions 387 cited references

Also sold as: Moxeza® Vigamox Vigamox®

About Moxifloxacin Ophthalmic

Moxifloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial eye infections like pink eye. Read the full Moxifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 251 Major 19 Moderate

All (282) Contraindicated (12) Major (251) Moderate (19)

Major

Moxifloxacin Ophthalmic Imipramine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Inotuzumab Ozogamicin Besponsa Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Insulin Afrezza Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Insulin Aspart, Recombinant Fiasp Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Insulin Bovine Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Insulin Degludec Tresiba Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Insulin Detemir Levemir Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Insulin Glulisine Apidra Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Insulin Lispro, Recombinant Admelog Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Isoflurane Fluriso An increased risk of QT interval prolongation and torsade de pointes Details Moxifloxacin Ophthalmic Itraconazole Sporanox Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ivabradine Corlanor Increased risk of QT prolongation Details Moxifloxacin Ophthalmic Ivosidenib Tibsovo An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ketoconazole Extina Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Lapatinib Tykerb Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Lefamulin Xenleta Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Moxifloxacin Ophthalmic Leuprolide Eligard Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Levofloxacin Levaquin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Linagliptin Tradjenta Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Liraglutide Saxenda Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Lixisenatide Changes in blood glucose with an increased risk of hypoglycemia or hyperglycemia and delayed therapeutic effect of antibiotic Details Moxifloxacin Ophthalmic Lofexidine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Lonafarnib Zokinvy An increased risk of QT interval prolongation and torsade de pointes Details Moxifloxacin Ophthalmic Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Moxifloxacin Ophthalmic Lumefantrine An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Macimorelin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Magnesium Sulfate May reduce absorption of fluoroquinolone antibiotics Details Moxifloxacin Ophthalmic Mavorixafor Xolremdi An increased risk of QT interval prolongation and torsade de pointes Details Moxifloxacin Ophthalmic Mefloquine Lariam® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Mercaptopurine Purinethol® An increased risk of hepatotoxicity Details Moxifloxacin Ophthalmic Metformin Fortamet® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Methadone Diskets Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Methotrexate Jylamvo Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Moxifloxacin Ophthalmic Methylprednisolone Depo-Medrol An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Metronidazole Flagyl An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Mifepristone Korlym Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Miglitol Glyset® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Milsaperidone An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Mirtazapine Mirataz Increased risk of QT interval prolongation and torsades de pointes Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.